Biblio

Latif S., Chiapusio G., Weston L.A.  2017.  Allelopathy and the Role of Allelochemicals in Plant Defence. HOW PLANTS COMMUNICATE WITH THEIR BIOTIC ENVIRONMENT. 82:19-54.

Vigan M.  2014.  Allergic contact dermatitis caused by sodium chondroitin sulfate contained in a cosmetic cream. CONTACT DERMATITIS. 70:383+.

Castelain F, Kerre S, Carlet C, Goossens A, Girardin P, Pelletier F, Aubin F.  2020.  Allergic contact dermatitis from carbomers: two case report. CONTACT DERMATITIS. 83:326-328.

Castelain F, Kerre S, Carlet C, Goossens A, Girardin P, Pelletier F, Aubin F.  2020.  Allergic contact dermatitis from carbomers: two case report. CONTACT DERMATITIS. 83:326-328.

Guichard A., Fanian F., Girardin P., Humbert P..  2014.  Allergic patch test and contact dermatitis by in vivo reflectance confocal microscopy. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE. 141:805-807.

Doc A., Capelli E., Le Pabic F., Pouessel G., Deschildre A., Morisset M., Rame J-M, Amandine B, Emilie C, Eline C et al..  2020.  Allergodiet: A working group of dietician-nutritionists in allergology. REVUE FRANCAISE D ALLERGOLOGIE. 60:143-149.

Macchia D., Cortellini G., Meucci E., Mauro M., Quercia O., Severino M., Massolo A., Passalacqua G..  2017.  Allergy to vespa crabro venom: Venom Immunotherapy with vespula vs vespa crabro. ALLERGY. 72:681-682.

Macchia D., Cortellini G., Meucci E., Mauro M., Quercia O., Severino M., Massolo A., Passalacqua G..  2017.  Allergy to vespa crabro venom: Venom Immunotherapy with vespula vs vespa crabro. ALLERGY. 72:681-682.

Abdel-Daim MM, Abo-EL-Sooud K, Aleya L, Bungau SG, Najda A, Saluja R.  2018.  Alleviation of Drugs and Chemicals Toxicity: Biomedical Value of Antioxidants. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY. 2018:6276438.

Sheveleva A, Finot C.  2021.  All-fibered high-quality 28-GHz to 112 GHz pulse sources based on nonlinear compression of optical temporal besselons. 2021 CONFERENCE ON LASERS AND ELECTRO-OPTICS EUROPE & EUROPEAN QUANTUM ELECTRONICS CONFERENCE (CLEO/EUROPE-EQEC).

Vedrine L.  2020.  Allocation of European Structural Funds, decentralization and strategic spatial interactions. REGIONAL STUDIES. 54:72-82.

Beal S, Remila E, Solal P.  Submitted.  Allocation rules for cooperative games with restricted communication and a priori unions based on the Myerson value and the average tree solution. JOURNAL OF COMBINATORIAL OPTIMIZATION.

Giebel S, Labopin M, Socie G, Yakoub-Agha I, Klein S, Wagner-Drouet EMaria, Blaise D, Nguyen-Quoc S, Bourhis JHenri, Thiebaut A et al..  2020.  Allogeneic HCT for Adults with B-Cell Precursor Acute Lymphoblastic Leukemia Harboring IKZF1 Gene Mutations. A Study by the Acute Leukemia Working Party of the EBMT. BONE MARROW TRANSPLANTATION. 55:26-27.

Giebel S, Labopin M, Socie G, Yakoub-Agha I, Klein S, Wagner-Drouet EMaria, Blaise D, Nguyen-Quoc S, Bourhis JHenri, Thiebaut A et al..  2020.  Allogeneic HCT for Adults with B-Cell Precursor Acute Lymphoblastic Leukemia Harboring IKZF1 Gene Mutations. A Study by the Acute Leukemia Working Party of the EBMT. BONE MARROW TRANSPLANTATION. 55:26-27.

Giebel S, Labopin M, Gorin NClaude, Milpied N, Petersen E, Potter MN, Cornelissen JJ, Caillot D, Niederwieser D, Montserrat R et al..  2014.  Allogeneic HCT with Reduced Intensity Conditioning Versus Autologous HCT for > 55 Years Old Patients with Acute Lymphoblastic Leukemia in First Complete Remission: An Analysis from Acute Leukemia Working Party of the EBMT. BLOOD. 124

Giebel S, Labopin M, Gorin NClaude, Milpied N, Petersen E, Potter MN, Cornelissen JJ, Caillot D, Niederwieser D, Montserrat R et al..  2014.  Allogeneic HCT with Reduced Intensity Conditioning Versus Autologous HCT for > 55 Years Old Patients with Acute Lymphoblastic Leukemia in First Complete Remission: An Analysis from Acute Leukemia Working Party of the EBMT. BLOOD. 124

Bazarbachi A, Labopin M, Kharfan-Dabaja MA, Schwerdtfeger R, Volin L, Bourhis JHenri, Socie G, Daguindau E, Gedde-Dahl T, Rambaldi A et al..  2016.  Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status. HAEMATOLOGICA. 101:E34-E37.

Bazarbachi A., Labopin M., Kharfan-Dabaja M., Schwerdtfeger R., Volin L., Bourhis J.H, Socie G., Deconinck E., Gedde-Dahl T., Rambaldi A. et al..  2015.  Allogeneic hematopoietic cell transplantation in AML with normal karyotype and isolated NPM1 mutation: a retrospective analysis from the Acute Leukemia Working Party of EBMT. BONE MARROW TRANSPLANTATION. 50:S259-S260.

Bazarbachi A, Labopin M, Kharfan-Dabaja MA, Schwerdtfeger R, Volin L, Bourhis J-H, Socie G, Deconinck E, Gedde-Dahl T, Rambaldi A et al..  2014.  Allogeneic Hematopoietic Cell Transplantation in AML with Normal Karyotype and NPM1 Mutated FLT3-ITD Negative: A Retrospective Analysis from the Acute Leukemia Working Party of EBMT. BLOOD. 124

Bazarbachi A., Labopin M., Kharfan-Dabaja M., Schwerdtfeger R., Volin L., Bourhis J.H, Socie G., Deconinck E., Gedde-Dahl T., Rambaldi A. et al..  2015.  Allogeneic hematopoietic cell transplantation in AML with normal karyotype and isolated NPM1 mutation: a retrospective analysis from the Acute Leukemia Working Party of EBMT. BONE MARROW TRANSPLANTATION. 50:S259-S260.

Guillaume T, Beguin Y, Tabrizi R, Nguyen S, Blaise D, Deconinck E, Redjoul R, Cornillon J, Guillerm G, Contentin N et al..  2015.  Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC). EUROPEAN JOURNAL OF HAEMATOLOGY. 94:265-269.

Decroocq J, Itzykson R, Vigouroux S, Michallet M, Yakoub-Agha I, Beckerich F, Huynh A, Suarez F, Chevallier P, Quoc SNguyen et al..  2015.  Allogeneic Hematopoietic Stem Cell Transplantation Offers Similar Outcome after Myeloablative and Sequential Conditioning Regimen in Patients with Primary Refractory or Relapsed Acute Myeloid Leukemia: A Study from the Societe Francaise De Greffe De Moell. BLOOD. 126

Decroocq J, Itzykson R, Vigouroux S, Michallet M, Yakoub-Agha I, Beckerich F, Huynh A, Suarez F, Chevallier P, Quoc SNguyen et al..  2015.  Allogeneic Hematopoietic Stem Cell Transplantation Offers Similar Outcome after Myeloablative and Sequential Conditioning Regimen in Patients with Primary Refractory or Relapsed Acute Myeloid Leukemia: A Study from the Societe Francaise De Greffe De Moell. BLOOD. 126

Chantepie SP, Michallet M, Blaise D, Maury S, Deconinck E, Tabrizi R, Contentin N, Mohty M, Nguyen S, Lioure B et al..  2014.  Allogeneic Stem Cell Transplantation (Allo-SCT) for De Novo Ph plus Acute Myeloid Leukemia: A Study from the French Society of Bone Marrow Transplantation and Cell Therapies. BLOOD. 124

Chantepie S.P, Michallet M., Blaise D., Maury S., Deconinck E., Tabrizi R., Contentin N., Mohty M., Nguyen S., Lioure B. et al..  2015.  Allogeneic stem cell transplantation (allo-SCT) for de novo Ph plus AML: a study from the French Society of Bone Marrow Transplantation and Cell Therapy. BONE MARROW TRANSPLANTATION. 50:1586-1588.